Prognostic Evaluation of Patients With Luminal B Immunophenotype, Submitted to Neoadjuvant Chemotherapy Attended at Dr Arnaldo Vieira De Carvalho Cancer Institute From 2006 to 2014

doi 10.29289/259453942019v29s1ep28
Full Text
Abstract

Available in full text

Date
Authors
Publisher

v29s1

Related search

Evaluation of Patients With Invasive Breast Carcinoma Submitted to Neoadjuvant Chemotherapy Attended at Dr Arnaldo Vieira De Carvalho Cancer Institute Form 2006 to 2014

2019English

HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy

Frontiers in Immunology
AllergyImmunology
2018English

Evaluation of Prognostic Factors and Validation of Tumor Response Ratios After Neoadjuvant Chemotherapy in Patients With Breast Cancer

Journal of Breast Disease
2016English

Neoadjuvant Chemotherapy Exerts Selection Pressure Towards Luminal Phenotype Breast Cancer

Breast Care
SurgeryOncology
2017English

Progesterone Receptor Loss Identifies Luminal-Type Local Advanced Breast Cancer With Poor Survival in Patients Who Fail to Achieve a Pathological Complete Response to Neoadjuvant Chemotherapy

Oncotarget
Oncology
2015English

MRP1 but Not MDR1 Is Associated With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2013English

Prognostic Evaluation of Platelet to Lymphocyte Ratio in Patients With Colorectal Cancer

Oncotarget
Oncology
2017English

Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal a Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy With Epirubicin Plus Paclitaxel

PLoS ONE
Multidisciplinary
2014English

Evaluation of the Response of Breast Cancer Patients to Neoadjuvant Chemotherapy by Combined Contrast‑enhanced Ultrasonography and Ultrasound Elastography

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy